Koers Cell MedX Corp OTC Bulletin Board
Aandelen
US15115X1072
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2022 | 0,01 0,01 | Omzet 2023 | 0 0 | Marktkapitalisatie | 6,29K 5,9K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 1.135.153.669 x |
Nettoschuld 2022 | 592K 556K | Nettoschuld 2023 | 903K 847K | EV/omzet 2023 | 329.116.944 x |
K/w-verhouding 2022 |
-9,01
x | K/w-verhouding 2023 |
-0,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 20,34% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 24-11-14 |
George Adams
CHM | Chairman | 76 | 23-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27-04-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08-06-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,17% | 42,86 mld. | |
+10,92% | 42,74 mld. | |
+44,30% | 41,36 mld. | |
-6,20% | 27,68 mld. | |
+5,23% | 25,15 mld. | |
-24,79% | 18,63 mld. | |
+26,69% | 12,37 mld. | |
-3,13% | 11,92 mld. | |
+6,57% | 11,21 mld. |
- Beurs
- Aandelen
- Koers CMXC
- Koers